In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Practice Patterns Science Inc.

Division of Cigna Corp.

Latest From Practice Patterns Science Inc.

Express Scripts' Friendly Data Play

PBMs have historically positioned themselves as drug-industry antagonists, pushing generic substitution and aggressively driving prices lower. But now one independent PBM is arguing that far from being in the enemy camp, branded pharmaceuticals, even high cost ones, can actually contribute to reducing overall medical costs by lowering spending in other areas. And they're developing the data to prove it.
BioPharmaceutical Clinical Trials

Higher Rx Costs Can Lead to Higher Savings

Most drug companies have experienced managed care as an unrelenting force for price discounts and profit erosion. But all along, managed care has also held out the promise of demonstrating that drug therapies, even expensive ones, can reduce health care costs by saving money on other medical expenditures.
BioPharmaceutical Reimbursement
See All

Company Information

  • Industry
  • Services
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cigna Corp.
  • Senior Management
  • Doug Cave, CEO & CSO
  • Contact Info
  • Practice Patterns Science Inc.
    Phone: (314) 770-1952
    1400 Riverport Drive
    Maryland Heights, MO 63043